Abstract
Adults with congenital heart disease are at risk for atrial and ventricular arrhythmias that can lead to an increased morbidity as well as mortality. When catheter ablation is not an option or unsuccessful, antiarrhythmic drugs are the mainstay of treatment. There is limited data on the use of antiarrhythmics in this population. The purpose of this article is to discuss the practical aspects of the use of antiarrhythmics in adults with congenital heart disease. Several tables have been provided to provide clinicians a reference for daily use.
Original language | English |
---|---|
Pages (from-to) | 295-309 |
Number of pages | 15 |
Journal | Cardiac Electrophysiology Clinics |
Volume | 9 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2017 |
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Keywords
- Anticoagulation
- Arrhythmia
- Congenital heart disease
- Drug therapy